Assignee
EXONATE LTD
GB·4 granted patents·1 pending application·1 citations·filing 2016–2024
Top patents by PatentIndex Score
5 records- 0190US12024504B21-methyl-1H-pyrazol-3-yl derivatives for use in the treatment of neovascular diseasesEXONATE LTD·Filed 2022·Granted Jul 2, 2024·1 cites·3 claims
- 0273US12325704B2SRPK1 inhibitorsEXONATE LTD·Filed 2022·Granted Jun 10, 2025·0 cites·9 claims
- 0373US2024300929A11-methyl-1h-pyrazol-3-yl derivatives for use in the treatment of neovascular diseasesEXONATE LTD·Filed 2024·Application pending·0 cites
- 0461US11420969B2SRPK1 inhibitorsEXONATE LTD·Filed 2018·Granted Aug 23, 2022·0 cites·33 claims
- 0541US10696661B2CompoundsEXONATE LTD·Filed 2016·Granted Jun 30, 2020·0 cites·21 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →